Context: CEO of ANRF and Chief Economic Adviser argued that recent global supply disruptions have created a strategic opportunity for India to strengthen its research ecosystem.
About India’s Research Leap: Why Innovation and R&D Will Define India’s Strategic Future:
What it is?
- India’s transition towards indigenous innovation is essential for achieving technological self-reliance and reducing dependence on foreign intellectual property. As recent global supply disruptions have shown, critical technologies and supply chains are increasingly becoming instruments of geopolitical power.
India’s Current Research Scenario:
- Low R&D Expenditure: India spends only 0.64% of GDP on research and development, significantly below the global average.
- Limited Private Investment: Private enterprises finance only about 40% of India’s R&D expenditure, compared to over 75% in leading innovation economies.
- ANRF as Institutional Anchor: The Anusandhan National Research Foundation (ANRF), established as a statutory body, aims to strengthen collaboration among academia, industry, startups, and government.
- Large Public Funding Push: ANRF provides ₹1 lakh crore through the Research, Development and Innovation (RDI) Fund for private-sector innovation and ₹50,000 crore through ANRF Core for fundamental research.
Why Private Industry Matters?
- Catalytic Public Funding: ANRF acts as a de-risking catalyst, providing patient capital that encourages firms to undertake high-risk, long-term research rather than replacing private investment.
- Multiplier Effect: Every ₹1 of ANRF support can mobilise ₹5–10 of private investment, enabling the commercialisation and large-scale deployment of research outcomes.
- Bridging Lab to Market: Private firms possess the expertise, manufacturing capacity, and market access needed to convert research prototypes into commercially viable products.
- Multiple Collaboration Pathways: Companies can participate through co-investment, joint ventures with deep-tech start-ups, national missions, or CSR contributions to the ANRF Innovation Fund.
Lessons from India’s Pharmaceutical Success:
History proves that Indian industry can rise to major technological challenges when forced by shifts in global rules. In the mid-1990s, when India joined the World Trade Organization (WTO) and agreed to honor strict product patents in pharmaceuticals, many experts predicted the local drug sector—which specialized in reverse-engineering foreign molecules—would be completely wiped out by multinationals.
Instead of retreating, domestic drug firms chose to build capabilities from the ground up:
- They rapidly mastered process chemistry and conformed to the world’s most demanding international regulatory requirements.
- They transformed India into the trusted “pharmacy of the world,” proving that facing strict global rules can spark an industrial leap.
Opportunities Before India:
- Reversing the High-Value Brain Drain: Scaling up advanced R&D projects provides long-term employment and world-class research settings for the top doctoral talent India trains at public cost, keeping them from leaving for overseas labs.
- Capitalizing on Multi-Polar Supply Shifts: The current global environment actively rewards economies offering a reliable, safe alternative to a single dominant global supplier, opening up major export lanes for Indian technologies.
- Leveraging Digital Public Infrastructure: India can build next-generation software tools and automated services directly on top of its world-class, pre-existing open digital foundations.
- Maximizing Global Capability Centres (GCCs): The high concentration of multinational GCCs already operating inside India provides an immediate workspace to launch co-funded, pre-competitive technological challenges.
Key Challenges in the Innovation Landscape:
- The Legacy Focus on Incremental Gains: A heavily protected domestic market has historically encouraged local companies to focus on low-risk, incremental process updates rather than investing in disruptive, long-horizon technologies.
- Deep Capital Concentration in Hostile Economies: Rising industrial rivals command major resource advantages; for example, China invests 2.43% of its massive output into R&D, with three-quarters of that sum financed directly by its own corporations to lock in control over frontier technologies.
- Short-Term Corporate Vulnerability: The constant pressure on private executives to deliver immediate, short-term quarterly income results frequently suppresses corporate budgets for speculative, multi-year laboratory research.
- Archaic Procurement Paradigms: Government tenders have historically prioritized lowest-cost bids (L1 frameworks) rather than evaluating quality, value, and long-term domestic innovation elements.
Way Forward:
- Deploying the ₹1 Lakh Crore ANRF Fund: Fast-track the distribution of long-term anchor capital under the Research, Development, and Innovation Fund to finance high-risk, pre-commercial private research sectors.
- Building Insulated Corporate Research Units: Private firms must set up dedicated internal research units and corporate venture branches protected from the pressure of short-term quarterly returns.
- Updating Government Procurement Guidelines: Reform public tender frameworks to prioritize indigenously developed patents, ensuring state contracts provide a reliable market for local innovations.
- Forging Bipartisan Multi-Year Research Missions: Align public university laboratories, deep-tech startups, and private corporations behind target technological goals, such as advanced energy storage and local chip architectures.
Conclusion:
The state has established the necessary foundation by launching the ANRF and committing substantial long-term capital; the laboratories are ready, and the demographic dividend is available. Ultimately, it is now up to private industry to back this public catalyst with its own capital, shifting India from a consumer of global intellectual property into a vital engine of international innovation.
